Board of directors

Per-Anders Abrahamsson

Member of the Board since 2015
MD, PhD, was appointed as Associate Professor 1989 and Professor 2000 at Lund University. Dr Abrahamsson is also holding a position as Adjunct Professor at the University of Rochester Medical Center, New York, since 1993.

He has been working as a urologist for 40 years, and 20 years as Head of the Department of Urology, Skåne University Hospital. He is currently also acting as Immediate Past Secretary General of the European Association of Urology, and Executive Medical Director at Ferring Pharmaceuticals A/S and Board Member at Camurus AB.

Per-Anders Abrahamsson

Björn Dellgren

Member of the Board since 2008
CEO for Adenovir Pharma AB and Investments at P.U.L.S. AB (Sweden). Former Partner at BankInvest, (Denmark). Previous Director of Business Development at Pharmacia Corporation and various international positions in sales, marketing and business management at Pharmacia and the American pharmaceutical company, Lederle. Previous board member in Cellectis SA, (France), CliniGenetics SA, (France) and CMC Biologics, (Denmark).

Björn Dellgren

Göran Hellström

Chairman
Member of the Board since 2005
Partner and CEO at Navet AB. Chairman of the board at Handelsbanken, Helsingborg. Industrifakta AB. Board member at Lunicore Studentkonsult AB.

Göran Hellström

Svante Paulsson

Member of the Board since 2007
Responsible for Projects and Strategic Affairs in Backahill AB. Board Member in Backahill AB, Brinova Fastigheter AB and Rögle BK.

Svante Paulsson

Ken Tinebo

CEO, Member of the Board since 2015
Ken Tinebo, MBA, has more than 20 years of experience in the pharmaceutical industry and has held executive commercial roles at companies such as Danone Medical Nutrition, Orion Pharma, Astra Zeneca and Pharmacia. 
Cernelle’s CEO since August 2015.

Ken Tinebo